China Health Industries Holdings, Inc. Reports Financial Results for the Third Quarter Ended March 31, 2020
Harbin, China--(Newsfile Corp. - May 15, 2020) - China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries", the "Company" or "Us"), a holding company with the operations in its subsidiaries in China, specializing in research & development, production, marketing and distribution of hemp derivative products, medicines and health supplement products, today announced the financial results for its third quarter ended March 31, 2020.Mr. Xin Sun, Chief Executive Officer and...
2020-05-15 8:00 AM EDT
China Health Industries Holdings, Inc. Reports Financial Results for the Second Quarter Ended December 31, 2019
Harbin, China--(Newsfile Corp. - February 14, 2020) - China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries", the "Company" or "Us"), a holding company with the operations in its subsidiaries in China, specializing in research & development, production, marketing and distribution of hemp derivative products, medicines and health supplement products, today announced the financial results for its second quarter ended December 31, 2019.Mr. Xin Sun, Chief Executive...
2020-02-14 8:00 AM EST
China Health Industries Holdings, Inc. Reports Financial Results for the First Quarter Ended September 30, 2019
Harbin, China--(Newsfile Corp. - November 14, 2019) - China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries", the "Company" or "Us") (www.chinahealthindustries.com) is a holding company vertically integrated with the operations in its subsidiaries in China, specializing in R&D, production, marketing and distribution of hemp derivative products, medicines and health supplement products, today announced the financial results for its first quarter ended September 30,...
2019-11-14 11:51 AM EST
China Health Industries Holdings, Inc. Announces Sales Up 42% in 2019 Fiscal Year
Harbin, China--(Newsfile Corp. - September 11, 2019) - China Health Industries Holdings, Inc. (OCTQB: CHHE) ("China Health Industries", the "Company", "We" or "Us") , a holding company with the operations in its subsidiaries in China, specializing in research & development, production, marketing and distribution of hemp derivative products, medical drugs and health supplements, today announced the financial results for the fiscal year ended June 30, 2019.Mr. Xin Sun, Chief Executive Officer...
2019-09-11 6:00 AM EDT
China Health Industries Holdings, Inc. Reports Financial Results for the Third Quarter Ended March 31, 2019
Harbin, China--(Newsfile Corp. - May 15, 2019) - China Health Industries Holdings, Inc. (OCTQB: CHHE) ("China Health Industries", the "Company" or "Us") is a holding company vertically integrated with the operations in its subsidiaries in China, specializing in R&D, production, marketing and distribution of hemp derivative products, medical drugs and health supplements, today announced the financial results for its third quarter ended March 31, 2019.Mr. Xin Sun, Chief Executive Officer and...
2019-05-15 8:00 AM EDT
China Health Industries Holdings, Inc. Reports Financial Results for the Second Quarter Ended December 31, 2018
Harbin, China--(Newsfile Corp. - February 14, 2019) - China Health Industries Holdings, Inc. (OCTQB: CHHE) (“China Health Industries”, the “Company” or “Us”) (www.chinahealthindustries.com) is a holding company vertically integrated with the operations in its subsidiaries in China, specializing in R&D, production, marketing and distribution of hemp derivative products, medicines and health supplement products, today announced the financial results for its second quarter ended December 31,...
2019-02-14 8:30 AM EST
China Health Industries Holdings, Inc. Completed the Strategic Transformation from Traditional Health Supplement Products Manufacturer to Hemp Derivative Products Pioneer
Harbin, China--(Newsfile Corp. - December 20, 2018) - China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries", the "Company" or "Us") has completed the strategic transformation from being a traditional health supplement products manufacturer to a hemp derivative products pioneer. The Company's hemp derivative products have been launched into the Chinese market since May 2018, including Hemp Oil, Hemp Protein Powder, Hemp Polypeptide and Hemp Cosmetics. For the three...
2018-12-20 8:00 AM EST
Wholly-Owned Subsidiary of China Health Industries Holdings, Inc. Signed an OEM Contract
Harbin, China--(Newsfile Corp. - April 19, 2016) - Harbin Humankind Biology Technology Co., Limited ("Humankind"), the wholly-owned subsidiary of China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries" or "company"), signed a long-term OEM contract with Yantai Baobei Biotech Limited ("Baobei") in April, 2016. According to the OEM contract, Humankind is pointed as the original equipment manufacturer of health food for Baobei. The contract will be valid since April,...
2016-04-19 8:00 AM EDT
China Health Industries Holdings, Inc. Achieved Major Technological Breakthrough on Propolis and Black Ant Capsule
Harbin, China--(Newsfile Corp. - April 4, 2016) - China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries" or "company") today announced that the company has achieved a major technological breakthrough on its original product: Propolis and Black Ant Capsule.China Health Industries owns proprietary intellectual property rights of Propolis and Black Ant Capsule ("the product"), which is designed to adjust human immunes system. It has been approved by China Food and Drug...
2016-04-04 6:00 AM EDT